In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9

Swiech, Lukasz, Heidenreich, Matthias, Banerjee, Abhishek, Habib, Naomi, Li, Yinqing, Trombetta, John, Sur, Mriganka, Zhang, Feng·2015·Nature Biotechnology

Cited by (771)

Items 401–500 of 771

  1. The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders
    Jun Wan Shin, Jong‐Min Lee · 2017 · Therapeutic Advances in Neurological Disorders
  2. The mRNA-Binding Protein RBM3 Regulates Activity Patterns and Local Synaptic Translation in Cultured Hippocampal Neurons
    Sinem M. Sertel, Malena S. von Elling-Tammen, Silvio O. Rizzoli · 2020 · Journal of Neuroscience
  3. CRISPR/Cas9-mediated neuronal deletion of 5-lipoxygenase alleviates deficits in mouse models of epilepsy
    Qi-Wen Guan, Zhaojun Wang, Kai Zhang, Zhaoqian Liu, Hong-Hao Zhou, Danfeng Cao, Xiao‐Yuan Mao · 2024 · Journal of Advanced Research
  4. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson’s Disease
    Katelin E. Ahlers‐Dannen, Mackenzie M. Spicer, Rory Alan Fisher · 2020 · Molecular Pharmacology
  5. High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot
    Susanna Croci, Miriam Lucia Carriero, Katia Capitani, Sergio Daga, Francesco Donati, Elisa Frullanti, Vittoria Lamacchia, Rossella Tita, Annarita Giliberti, Floriana Valentino et al. · 2020 · European Journal of Human Genetics
  6. Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue
    Marcin Janowski, Małgorzata Milewska, Payman Zare, Aleksandra Pękowska · 2021 · Pharmaceuticals
  7. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application
    Bixi Sun, Hening Chen, Xiaoshu Gao · 2021 · Journal of Controlled Release
  8. Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead
    Radheshyam Jena, Sukriti Vishwas, Rajan Kumar, Jaskiran Kaur, Rubiya Khursheed, Monica Gulati, Thakur Gurjeet Singh, B Meenashi Vanathi, Aftab Alam, Bimlesh Kumar et al. · 2022 · European Journal of Pharmacology
  9. Amelioration of cold-induced sweetening in potato by RNAi mediated silencing of StUGPase encoding UDP-glucose pyrophosphorylase
    Sandeep Jaiswal, Krishnayan Paul, K. Venkat Raman, Saurabh Tyagi, Manjesh Saakre, Jyotsana Tilgam, Sougata Bhattacharjee, Joshitha Vijayan, Kalyan Kumar Mondal, Rohini Sreevathsa et al. · 2023 · Frontiers in Plant Science
  10. Massively parallel evaluation and computational prediction of the activities and specificities of 17 small Cas9s
    Sang-Yeon Seo, Seonwoo Min, Sungtae Lee, Jung Hwa Seo, Jinman Park, Hui Kwon Kim, Myungjae Song, Dawoon Baek, Sung‐Rae Cho, Seokjoong Kim · 2023 · Nature Methods
  11. CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
    Mingming Qin, Chunhao Deng, Liewei Wen, Guoqun Luo, Ya Meng · 2024 · Journal of Translational Medicine
  12. Epigenomic engineering for Down syndrome
    Alexios‐Fotios A. Mentis · 2016 · Neuroscience & Biobehavioral Reviews
  13. Emerging roles for long noncoding RNAs in learning, memory and associated disorders
    Eddie Grinman, Isabel Espadas, Sathyanarayanan V. Puthanveettil · 2019 · Neurobiology of Learning and Memory
  14. Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
    Ming Hu, Ines Cherkaoui, Shivani Misra, Guy A. Rutter · 2020 · Frontiers in Endocrinology
  15. Genomics and epigenomics of addiction
    Rafael J. Maldonado, Pablo Calvé, Alejandra García‐Blanco, Laura Domingo‐Rodriguez, Eric Senabre, Elena Martín‐García · 2021 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  16. Evasion of Pre-Existing Immunity to Cas9: A Prerequisite for Successful Genome Editing In Vivo?
    Wignakumar, Thirushan, Fairchild, Paul J. · 2019 · Current Transplantation Reports
  17. An RNA editing strategy rescues gene duplication in a mouse model of MECP2 duplication syndrome and nonhuman primates
    Dong Joo Yang, Xiaoqing Wu, Yinan Yao, Mengsi Duan, Xing Wang, Guoling Li, Aiguo Guo, Meixian Wu, Yuanhua Liu, Jin Zheng et al. · 2024 · Nature Neuroscience
  18. CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges
    Raya Kh. Yashooa, Ari Qadir Nabi, Shukur Wasman Smail, Sarkar Sardar Azeez, Wissam Albeer Nooh, Suhad Asad Mustafa, Abd Al-Bar Al-Farha, Nazzareno Capitanio, Mudhir Sabir Shekha · 2026 · Frontiers in Neurology
  19. Understanding the Potential of Genome Editing in Parkinson’s Disease
    David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes, Natasha I. Bloch · 2021 · International Journal of Molecular Sciences
  20. CRISPR Systems Suitable for Single AAV Vector Delivery
    Marta Stevanovic, Elena Piotter, Michelle E. McClements, Robert Edward MacLaren · 2021 · Current Gene Therapy
  21. Multi-omics profiling of single nuclei from frozen archived postmortem human pituitary tissue
    Natalia Mendelev, Michel Zamojski, Mary Anne S. Amper, Wan Sze Cheng, Hanna Pinças, Venugopalan D. Nair, Elena Zaslavsky, Stuart C. Sealfon, Frederique Murielle Ruf-Zamojski · 2022 · STAR Protocols
  22. CRISPR for neuroscientists
    Georgios Kalamakis, Randall J. Platt · 2023 · Neuron
  23. An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept
    Arjen J. Boender, Marina Boon, H. Elliott Albers, Samantha R. Eck, Brandon A. Fricker, Aubrey M. Kelly, Joseph E. LeDoux, Simone Cristina Motta, Prerana Shrestha, Jack H. Taylor et al. · 2023 · Science Advances
  24. KMT2C knockout generates ASD-like behaviors in mice
    Bastián Brauer, Nicolás Merino-Véliz, Constanza Ahumada-Marchant, Gloria Arriagada, Fernando J. Bustos · 2023 · Frontiers in Cell and Developmental Biology
  25. Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo
    Han Zhang, Karen L. Kelly, Jonathan L. C. Lee, Dimas Echeverria, David Cooper, Rebecca Panwala, Nadia Amrani, Zexiang Chen, Nicholas Gaston, Atish A. Wagh et al. · 2023 · Nucleic Acids Research
  26. A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD
    Tristan X. McCallister, Colin K.W. Lim, Mayuri Singh, Sijia Zhang, Najah S. Ahsan, William M. Terpstra, Alisha Y. Xiong, M. Alejandra Zeballos C., Jackson E. Powell, Jenny M. Drnevich et al. · 2025 · Nature Communications
  27. Gene therapy research in Asia
    H-X Deng, Yunbing Wang, Q-r Ding, DL Li, Yu-quan Wei · 2017 · Gene Therapy
  28. Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells
    Haote Han, Na Chen, Xionggao Huang, Bing Liu, Jingkui Tian, Hetian Lei · 2019 · Journal of Biological Chemistry
  29. Death receptor-based enrichment of Cas9-expressing cells
    Clarissa Liesche, L. Venkatraman, Sabine Aschenbrenner, Stefanie Große, Dirk Grimm, Roland Eils, Joël Beaudouin · 2016 · BMC Biotechnology
  30. Adeno-Associated Virus–Mediated Delivery of CRISPR–Cas Systems for Genome Engineering in Mammalian Cells
    Thomas Gaj, David V. Schaffer · 2016 · Cold Spring Harbor Protocols
  31. Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review
    Min Huang, Qi Qi, Tao Xu · 2023 · Frontiers in Molecular Neuroscience
  32. Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier
    Ruosen Xie, Yuyuan Wang, Jacobus C. Burger, Dongdong Li, Min Zhu, Shaoqin Gong · 2023 · Med-X
  33. RNA-binding protein CUGBP1 regulates insulin secretion via activation of phosphodiesterase 3B in mice
    Kui Zhai, Lei Gu, Zhiguang Yang, Yang Mao, Meng Jin, Yan Chang, Qi Yuan, Véronique Leblais, Huiwen Wang, Rodolphe Fischmeister et al. · 2016 · Diabetologia
  34. Local knockdown of Nav1.6 relieves pain behaviors induced by BmK I
    Shichao Qin, Feng Jiang, You Zhou, Guokun Zhou, Ye Pin, Yonghua Ji · 2017 · Acta Biochimica et Biophysica Sinica
  35. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy
    Guohong Zhou, yajiang duan, Gaoen Ma, Wenyi Wu, Zhengping Hu, Na Chen, Yewlin E. Chee, Jing Z Cui, Arif Samad, Joanne Aiko Matsubara et al. · 2017 · Investigative Ophthalmology & Visual Science
  36. PDGFRβ plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes
    Yanhui Yang, Xionggao Huang, Gaoen Ma, Jing Z Cui, Joanne Aiko Matsubara, Andrius Kazlauskas, Jun Zhao, Jiantao Wang, Hetian Lei · 2020 · Experimental Eye Research
  37. CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
    Safikur Rahman, Manali Datta, Jihoe Kim, Arif Tasleem Jan · 2019 · Seminars in Cell and Developmental Biology
  38. Engineering of the Epigenome: Synthetic Biology to Define Functional Causality and Develop Innovative Therapies
    Jörg Tost · 2016 · Epigenomics
  39. Drug Discovery Oncology in a Mouse: concepts, Models and Limitations
    Jason E. Long, Maja Jankovic, Danilo Maddalo · 2021 · Future Science OA
  40. Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks
    Sabina Marciano, Tudor M. Ionescu, Ran Sing Saw, Rachel Y. Cheong, Deniz Kirik, Andreas Maurer, Bernd Jürgen Pichler, Kristina Herfert · 2022 · Proceedings of the National Academy of Sciences
  41. Genetic modulation of the HTR2A gene reduces anxiety-related behavior in mice
    T. Rohn, D. Radin, Tracy Brandmeyer, Barry J. Linder, E. Andriambeloson, Stéphanie Wagner, James Kehler, A. Vasileva, Huai-En Wang, John L. Mee et al. · 2023 · PNAS Nexus
  42. Recent advances and current status of gene therapy for epilepsy
    Aojie Cai, Kai Gao, Fan Zhang, Yuwu Jiang · 2024 · World Journal of Pediatrics
  43. Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
    Dmitrii Degtev, Jack P. K. Bravo, Aikaterini Emmanouilidi, Aleksandar Zdravković, Oi Kuan Choong, Julia Liz Touza, Niklas Selfjord, Isabel Weisheit, Margherita Francescatto, Pınar Akçakaya et al. · 2024 · Nature Communications
  44. Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) Vectors
    Julia Fakhiri, Manuela Nickl, Dirk Grimm · 2019 · Methods in molecular biology
  45. Imaging and Manipulating Pituitary Function in the Awake Mouse
    Ombeline Hoa, Chrystel Lafont, Pierre Fontanaud, Anne Guillou, Yasmine Kemkem, Rhonda Denise Kineman, Raul Miguel Luque, Tatiana Fiordelisio, Paul Le Tissier, Patrice Mollard · 2019 · Endocrinology
  46. Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells
    Bing Liu, Jingyuan Song, Haote Han, Zhengping Hu, Na Chen, Jing Z Cui, Joanne Aiko Matsubara, Jingxiang Zhong, Hetian Lei · 2019 · Laboratory Investigation
  47. Genetically Engineering the Nervous System with CRISPR-Cas
    Alfredo Sandoval, Hajira Elahi, Jonathan E. Ploski · 2020 · eNeuro
  48. 多样化CRISPR技术在动物体内基因编辑研究中的应用和进展
    马迅, Xun Ma, 黄芯渝, 谭晞彦, 崔雍建, 钟礼瞬, 冯波, Avery Sum-Yu Wong, Hei-Yin Tam, Samuel Yung-Kin Tsui et al. · 2018 · 动物学研究
  49. CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential
    Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri · 2025 · Cell Proliferation
  50. N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy
    Xudong Liu, Chuan-En Wang, Yan Hong, Ting Zhao, Guohao Wang, Marta A. Gaertig, Miao Sun, Shihua Li, Xiao‐Jiang Li · 2016 · PLoS Genetics
  51. The Dawn of In Vivo Gene Editing Era: A Revolution in the Making
    Sarfaraz K. Niazi · 2023 · Biologics
  52. Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies
    Amrutha Banda, Olivia Impomeni, Aparana Singh, Abdul Rasheed Baloch, Wenhui Hu, Dabbu Kumar Jaijyan · 2024 · Vaccines
  53. Cell adhesion molecules and sleep
    Emma Kate O’Callaghan, Maria Neus Ballester Roig, Valérie Mongrain · 2016 · Neuroscience Research
  54. The application of CRISPR technology to high content screening in primary neurons
    Ben L. Callif, Brian Maunze, Nick L. Krueger, Matthew T. Simpson, Murray G. Blackmore · 2017 · Molecular and Cellular Neuroscience
  55. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation
    Lee A. Campbell, Christopher T. Richie, Nishad S. Maggirwar, Brandon K. Harvey · 2019 · Journal of Neuroimmune Pharmacology
  56. Visualization and correction of social abnormalities-associated neural ensembles in adult MECP2 duplication mice
    Le Sun, Ruiguo Chen, Long Li, Bo Yuan, Kun Song, Na Pan, Tian‐Lin Cheng, Shiyang Chang, Kunzhang Lin, Xiaobin He et al. · 2020 · 中国科学通报:英文版
  57. Research on genodermatoses using novel genome‐editing tools
    Janin Lehmann, Christina Seebode, Steffen Emmert · 2017 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  58. Viral vectors as a novel tool for clinical and neuropsychiatric research applications
    Yao Wang, Zhiwei Hu, Peijun Ju, Shan Yin, Fujie Wang, Oudong Pan, Jinghong Chen · 2018 · General Psychiatry
  59. Engineering CRISPR-Cas9 RNA–Protein Complexes for Improved Function and Delivery
    Romain Rouet, Lorena de Oñate, Jie Li, Niren Murthy, Ross C. Wilson · 2018 · The CRISPR Journal
  60. Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
    Ji He, Riya Biswas, Piyush Bugde, Jiawei Li, Dong‐Xu Liu, Yan Li · 2022 · Pharmaceutics
  61. Doxycycline-dependent Cas9-expressing pig resources for conditional in vivo gene nullification and activation
    Qin Jin, Xiaoyi Liu, Zhenpeng Zhuang, Jiayuan Huang, Shixue Gou, Hui Shi, Yu Zhao, Zhen Ouyang, Zhaoming Liu, Lei Li et al. · 2023 · Genome biology
  62. Acoustically targeted noninvasive gene therapy in large brain volumes
    Shirin Nouraein, Sangsin Lee, Vidal A. Saenz, Huckie C. Del Mundo, Joycelyn Yiu, Jerzy O. Szablowski · 2023 · Gene Therapy
  63. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools
    Akbar Hasanzadeh, Arefeh Ebadati, Lida Dastanpour, Amir Reza Aref, Parham Sahandi Zangabad, Alireza Kalbasi, Xiaofeng Dai, Geeta Mehta, Amir Ghasemi, Yousef Fatahi et al. · 2023 · ACS Pharmacology & Translational Science
  64. Massively parallel in vivo Perturb-seq screening
    Xinhe Zheng, Patrick C. Thompson, Cassandra White, Xin Jin · 2025 · Nature Protocols
  65. Developmental history and application of CRISPR in human disease
    Puping Liang, Xiya Zhang, Yuxi Chen, Junjiu Huang · 2017 · The Journal of Gene Medicine
  66. Optimized CRISPR/Cas9-mediated in vivo genome engineering applicable to monitoring dynamics of endogenous proteins in the mouse neural tissues
    Takahiko Matsuda, Izumi Oinuma · 2019 · Scientific Reports
  67. Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion
    Qian Ban, Peng Yang, Shih‐Jie Chou, Li Qiao, Haidong Xia, Jingjing Xue, Fang Wang, Xiaobin Xu, Na Sun, Ryan Y. Zhang et al. · 2021 · Small
  68. BAd-CRISPR: Inducible gene knockout in interscapular brown adipose tissue of adult mice
    Steven M. Romanelli, Kenneth T. Lewis, Akira Nishii, Alan C. Rupp, Ziru Li, Hiroyuki Mori, Rebecca L. Schill, Brian S. Learman, Christopher J. Rhodes, Ormond A. MacDougald · 2021 · Journal of Biological Chemistry
  69. A peptide delivery system sneaks CRISPR into cells
    Xingang Guan, Zhimin Luo, Wujin Sun · 2018 · Journal of Biological Chemistry
  70. AAV-mediated FOXG1 gene editing in human Rett primary cells
    Susanna Croci, Miriam Lucia Carriero, Katia Capitani, Sergio Daga, Francesco Donati, Filomena Tiziana Papa, Elisa Frullanti, Diego Lopergolo, Vittoria Lamacchia, Rossella Tita et al. · 2020 · European Journal of Human Genetics
  71. Genetic Background Matters: Population-Based Studies in Model Organisms for Translational Research
    Valeria Olguín, Anyelo Durán, Macarena Las Heras, Juan Carlos Rubilar, Francisco A. Cubillos, Patricio Olguı́n, Andrés D. Klein · 2022 · International Journal of Molecular Sciences
  72. Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy
    Roeland Buckinx, Jean‐Pierre Timmermans · 2016 · Histochemistry and Cell Biology
  73. CRISPR-Mediated Ophthalmic Genome Surgery
    Galaxy Y. Cho, Yazeed L. Abdulla, Jesse D. Sengillo, Sally Justus, Kellie A. Schaefer, Alexander G. Bassuk, Stephen H. Tsang, Vinit B. Mahajan · 2017 · Current Ophthalmology Reports
  74. Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission
    Can Peng, Yijin Yan, Veronica J. Kim, Staci E. Engle, Jennifer N. Berry, J. Michael McIntosh, Rachael L. Neve, Ryan M. Drenan · 2018 · European Journal of Neuroscience
  75. Spadin Modulates Astrocytic Passive Conductance via Inhibition of TWIK-1/TREK-1 Heterodimeric Channels
    Yeonju Bae, Jae Hyouk Choi, Kanghyun Ryoo, Ajung Kim, O‐Sung Kwon, Hyun‐Gug Jung, Eun Mi Hwang, Jae‐Yong Park · 2020 · International Journal of Molecular Sciences
  76. The role of gap junctions in cell death and neuromodulation in the retina
    Gergely Szarka, Márton Balogh, Ádám J. Tengölics, Alma Ganczer, Béla Völgyi, Tamás Kovács‐Öller · 2021 · Neural Regeneration Research
  77. CRISPR-mediated rapid generation of neural cell-specific knockout mice facilitates research in neurophysiology and pathology
    Dan Xiao, Weifeng Zhang, Qing Wang, Xing Li, Yuan Zhang, Javad Rasouli, Giacomo Casella, Bogoljub Ćirić, Mark T. Curtis, Abdolmohamad M. Rostami et al. · 2021 · Molecular Therapy — Methods & Clinical Development
  78. CRISPR-engineered genome editing for the next generation neurological disease modeling
    Weijun Feng, Hai‐Kun Liu, Daisuke Kawauchi · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  79. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Joshua Kuruvilla, Andrew Octavian Sasmita, Anna Pick Kiong Ling · 2018 · Neurological Sciences
  80. Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice
    Wan Zhu, Daniel Saw, Miriam Weiss, Zhengda Sun, Meng Wei, Sonali S. Shaligram, Sen Wang, Hua Su · 2018 · Translational Stroke Research
  81. Inactive Cas9 blocks vitreous-induced expression of Mdm2 and proliferation and survival of retinal pigment epithelial cells
    Na Chen, Zhengping Hu, Yanhui Yang, Haote Han, Hetian Lei · 2019 · Experimental Eye Research
  82. Expansion of the CRISPR/Cas Genome-Sculpting Toolbox: Innovations, Applications and Challenges
    Asiya Batool, Fayaz Ahmad Malik, Khurshid Iqbal Andrabi · 2020 · Molecular Diagnosis & Therapy
  83. An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications
    Indra Rautela, Pooja Uniyal, Priya Thapliyal, Neha Chauhan, Vimlendu Bhushan Sinha, Manish Dev Sharma · 2021 · Gene
  84. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses
    Usman Shah Gilani, Memoona Shaukat, Arisha Rasheed, Mehak Shahid, Fareeda Tasneem, Muhammad Imran Arshad, Naeem Rashid, Naveed Shahzad · 2018 · Journal of Medical Virology
  85. Protocol to Design, Clone, and Validate sgRNAs for In Vivo Reverse Genetic Studies
    Avery C. Hunker, Larry S. Zweifel · 2020 · STAR Protocols
  86. Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing Tools
    Uijin Kim, Nahyun Kim, Ha Youn Shin · 2020 · Cells
  87. CRISPR Gene-Editing Models Geared Toward Therapy for Hereditary and Developmental Neurological Disorders
    Poh Kuan Wong, Fook‐Choe Cheah, Saiful Effendi Syafruddin, M. Aiman Mohtar, Norazrina Azmi, Pei Yuen Ng, Eng Wee Chua · 2021 · Frontiers in Pediatrics
  88. Regenerative medicine: targeted genome editing in vivo
    Lixia Wang, Jun Wu, Weiwei Fang, Guang‐Hui Liu, Juan Carlos Izpisúa Belmonte · 2015 · Cell Research
  89. Translational Research in Muscular Dystrophy
    Shin’ichi Takeda, Yuko Miyagoe‐Suzuki, Madoka Mori‐Yoshimura · 2016 · Springer eBooks
  90. Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review
    Mohammad Banazadeh, Ardavan Abiri, Mohammad Mahdi Poortaheri, Lida Asnaashari, Mohammad Amin Langarizadeh, Hamid Forootanfar · 2024 · International Journal of Biological Macromolecules
  91. Targeting neuronal epigenomes for brain rejuvenation
    Sara Zocher · 2024 · The EMBO Journal
  92. Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response
    Christine Germeys, Tijs Vandoorne, Kristofer Davie, Suresh Kumar Poovathingal, Kara Heeren, Wendy Vermeire, Fatemeharefeh Nami, Matthieu Moisse, Annelies Quaegebeur, Annerieke S. R. Sierksma et al. · 2024 · Cell Reports
  93. Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities
    Kexin Xiong, Xiaxia Wang, Caicai Feng, Kaixiang Zhang, Di Chen, Sen Yang · 2025 · Advanced Biology
  94. Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling
    Norihide Jo, Yuko Sogabe, Yosuke Yamada, Tomoyo Ukai, Harunobu Kagawa, Kanae Mitsunaga, Knut Woltjen, Yasuhiro Yamada · 2018 · Cancer Science
  95. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases
    Desh Deepak Singh, R. David Hawkins, Riitta Lahesmaa, Subhash Kumar Tripathi · 2019 · Seminars in Cell and Developmental Biology
  96. A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System
    Anna Bellizzi, Nicholas Ahye, Gauthami S. Jalagadugula, Hassen S. Wollebo · 2019 · Journal of Neuroimmune Pharmacology
  97. In vivo multiplex gene targeting with Streptococcus pyogens and Campylobacter jejuni Cas9 for pancreatic cancer modeling in wild-type animal
    Yoo Jin Chang, Jihyeon Bae, Yang Zhao, Geon Seong Lee, Jeong Pil Han, Yoon Hoo Lee, Ok Jae Koo, Sun-Min Seo, Yang‐Kyu Choi, Su Cheong Yeom · 2020 · Journal of Veterinary Science
  98. Neurogenethics: An emerging discipline at the intersection of ethics, neuroscience, and genomics
    Turhan Canli · 2015 · Applied & Translational Genomics
  99. Rabies virus-mediated connectivity tracing from single neurons
    Martin K. Schwarz, Stefan Remy · 2019 · Journal of Neuroscience Methods
  100. Nucleolus localization of SpyCas9 affects its stability and interferes with host protein translation in mammalian cells
    Renke Tan, Wenhao Du, Yiyang Liu, Xiaoji Cong, Meirong Bai, Chenxiao Jiang, Zengxia Li, Minjia Tan, K. Dengke, Qiang Huang et al. · 2020 · Genes & Diseases